Global Tardive Dyskinesia Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 282541
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Tardive Dyskinesia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Tardive Dyskinesia market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Tardive Dyskinesia global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dopamine-Depleting Medications segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Tardive Dyskinesia include Bausch Health, Neurocrine Biosciences, Teva Pharmaceuticals Industries, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Tardive Dyskinesia market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Dopamine-Depleting Medications

GABA Receptor Agonist Medications

Anticholinergic Medications

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Market segment by players, this report covers

Bausch Health

Neurocrine Biosciences

Teva Pharmaceuticals Industries

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Tardive Dyskinesia product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Tardive Dyskinesia, with revenue, gross margin and global market share of Tardive Dyskinesia from 2019 to 2022.

Chapter 3, the Tardive Dyskinesia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Tardive Dyskinesia market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Tardive Dyskinesia research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Tardive Dyskinesia

1.2 Classification of Tardive Dyskinesia by Type

1.2.1 Overview: Global Tardive Dyskinesia Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Tardive Dyskinesia Revenue Market Share by Type in 2021

1.2.3 Dopamine-Depleting Medications

1.2.4 GABA Receptor Agonist Medications

1.2.5 Anticholinergic Medications

1.3 Global Tardive Dyskinesia Market by Application

1.3.1 Overview: Global Tardive Dyskinesia Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Global Tardive Dyskinesia Market Size & Forecast

1.5 Global Tardive Dyskinesia Market Size and Forecast by Region

1.5.1 Global Tardive Dyskinesia Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Tardive Dyskinesia Market Size by Region, (2017-2022)

1.5.3 North America Tardive Dyskinesia Market Size and Prospect (2017-2028)

1.5.4 Europe Tardive Dyskinesia Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Tardive Dyskinesia Market Size and Prospect (2017-2028)

1.5.6 South America Tardive Dyskinesia Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Tardive Dyskinesia Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tardive Dyskinesia Market Drivers

1.6.2 Tardive Dyskinesia Market Restraints

1.6.3 Tardive Dyskinesia Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Bausch Health

2.1.1 Bausch Health Details

2.1.2 Bausch Health Major Business

2.1.3 Bausch Health Tardive Dyskinesia Product and Solutions

2.1.4 Bausch Health Tardive Dyskinesia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Bausch Health Recent Developments and Future Plans

2.2 Neurocrine Biosciences

2.2.1 Neurocrine Biosciences Details

2.2.2 Neurocrine Biosciences Major Business

2.2.3 Neurocrine Biosciences Tardive Dyskinesia Product and Solutions

2.2.4 Neurocrine Biosciences Tardive Dyskinesia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Neurocrine Biosciences Recent Developments and Future Plans

2.3 Teva Pharmaceuticals Industries

2.3.1 Teva Pharmaceuticals Industries Details

2.3.2 Teva Pharmaceuticals Industries Major Business

2.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Product and Solutions

2.3.4 Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Teva Pharmaceuticals Industries Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Tardive Dyskinesia Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Tardive Dyskinesia Players Market Share in 2021

3.2.2 Top 10 Tardive Dyskinesia Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Tardive Dyskinesia Players Head Office, Products and Services Provided

3.4 Tardive Dyskinesia Mergers & Acquisitions

3.5 Tardive Dyskinesia New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Tardive Dyskinesia Revenue and Market Share by Type (2017-2022)

4.2 Global Tardive Dyskinesia Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Tardive Dyskinesia Revenue Market Share by Application (2017-2022)

5.2 Global Tardive Dyskinesia Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Tardive Dyskinesia Revenue by Type (2017-2028)

6.2 North America Tardive Dyskinesia Revenue by Application (2017-2028)

6.3 North America Tardive Dyskinesia Market Size by Country

6.3.1 North America Tardive Dyskinesia Revenue by Country (2017-2028)

6.3.2 United States Tardive Dyskinesia Market Size and Forecast (2017-2028)

6.3.3 Canada Tardive Dyskinesia Market Size and Forecast (2017-2028)

6.3.4 Mexico Tardive Dyskinesia Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Tardive Dyskinesia Revenue by Type (2017-2028)

7.2 Europe Tardive Dyskinesia Revenue by Application (2017-2028)

7.3 Europe Tardive Dyskinesia Market Size by Country

7.3.1 Europe Tardive Dyskinesia Revenue by Country (2017-2028)

7.3.2 Germany Tardive Dyskinesia Market Size and Forecast (2017-2028)

7.3.3 France Tardive Dyskinesia Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Tardive Dyskinesia Market Size and Forecast (2017-2028)

7.3.5 Russia Tardive Dyskinesia Market Size and Forecast (2017-2028)

7.3.6 Italy Tardive Dyskinesia Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tardive Dyskinesia Revenue by Type (2017-2028)

8.2 Asia-Pacific Tardive Dyskinesia Revenue by Application (2017-2028)

8.3 Asia-Pacific Tardive Dyskinesia Market Size by Region

8.3.1 Asia-Pacific Tardive Dyskinesia Revenue by Region (2017-2028)

8.3.2 China Tardive Dyskinesia Market Size and Forecast (2017-2028)

8.3.3 Japan Tardive Dyskinesia Market Size and Forecast (2017-2028)

8.3.4 South Korea Tardive Dyskinesia Market Size and Forecast (2017-2028)

8.3.5 India Tardive Dyskinesia Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Tardive Dyskinesia Market Size and Forecast (2017-2028)

8.3.7 Australia Tardive Dyskinesia Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Tardive Dyskinesia Revenue by Type (2017-2028)

9.2 South America Tardive Dyskinesia Revenue by Application (2017-2028)

9.3 South America Tardive Dyskinesia Market Size by Country

9.3.1 South America Tardive Dyskinesia Revenue by Country (2017-2028)

9.3.2 Brazil Tardive Dyskinesia Market Size and Forecast (2017-2028)

9.3.3 Argentina Tardive Dyskinesia Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tardive Dyskinesia Revenue by Type (2017-2028)

10.2 Middle East & Africa Tardive Dyskinesia Revenue by Application (2017-2028)

10.3 Middle East & Africa Tardive Dyskinesia Market Size by Country

10.3.1 Middle East & Africa Tardive Dyskinesia Revenue by Country (2017-2028)

10.3.2 Turkey Tardive Dyskinesia Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Tardive Dyskinesia Market Size and Forecast (2017-2028)

10.3.4 UAE Tardive Dyskinesia Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tardive Dyskinesia Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Tardive Dyskinesia Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Tardive Dyskinesia Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Tardive Dyskinesia Revenue (USD Million) by Region (2017-2022)

Table 5. Global Tardive Dyskinesia Revenue Market Share by Region (2023-2028)

Table 6. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 7. Bausch Health Major Business

Table 8. Bausch Health Tardive Dyskinesia Product and Solutions

Table 9. Bausch Health Tardive Dyskinesia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Neurocrine Biosciences Corporate Information, Head Office, and Major Competitors

Table 11. Neurocrine Biosciences Major Business

Table 12. Neurocrine Biosciences Tardive Dyskinesia Product and Solutions

Table 13. Neurocrine Biosciences Tardive Dyskinesia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Teva Pharmaceuticals Industries Corporate Information, Head Office, and Major Competitors

Table 15. Teva Pharmaceuticals Industries Major Business

Table 16. Teva Pharmaceuticals Industries Tardive Dyskinesia Product and Solutions

Table 17. Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Global Tardive Dyskinesia Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 19. Global Tardive Dyskinesia Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 20. Breakdown of Tardive Dyskinesia by Company Type (Tier 1, Tier 2 and Tier 3)

Table 21. Tardive Dyskinesia Players Head Office, Products and Services Provided

Table 22. Tardive Dyskinesia Mergers & Acquisitions in the Past Five Years

Table 23. Tardive Dyskinesia New Entrants and Expansion Plans

Table 24. Global Tardive Dyskinesia Revenue (USD Million) by Type (2017-2022)

Table 25. Global Tardive Dyskinesia Revenue Share by Type (2017-2022)

Table 26. Global Tardive Dyskinesia Revenue Forecast by Type (2023-2028)

Table 27. Global Tardive Dyskinesia Revenue by Application (2017-2022)

Table 28. Global Tardive Dyskinesia Revenue Forecast by Application (2023-2028)

Table 29. North America Tardive Dyskinesia Revenue by Type (2017-2022) & (USD Million)

Table 30. North America Tardive Dyskinesia Revenue by Type (2023-2028) & (USD Million)

Table 31. North America Tardive Dyskinesia Revenue by Application (2017-2022) & (USD Million)

Table 32. North America Tardive Dyskinesia Revenue by Application (2023-2028) & (USD Million)

Table 33. North America Tardive Dyskinesia Revenue by Country (2017-2022) & (USD Million)

Table 34. North America Tardive Dyskinesia Revenue by Country (2023-2028) & (USD Million)

Table 35. Europe Tardive Dyskinesia Revenue by Type (2017-2022) & (USD Million)

Table 36. Europe Tardive Dyskinesia Revenue by Type (2023-2028) & (USD Million)

Table 37. Europe Tardive Dyskinesia Revenue by Application (2017-2022) & (USD Million)

Table 38. Europe Tardive Dyskinesia Revenue by Application (2023-2028) & (USD Million)

Table 39. Europe Tardive Dyskinesia Revenue by Country (2017-2022) & (USD Million)

Table 40. Europe Tardive Dyskinesia Revenue by Country (2023-2028) & (USD Million)

Table 41. Asia-Pacific Tardive Dyskinesia Revenue by Type (2017-2022) & (USD Million)

Table 42. Asia-Pacific Tardive Dyskinesia Revenue by Type (2023-2028) & (USD Million)

Table 43. Asia-Pacific Tardive Dyskinesia Revenue by Application (2017-2022) & (USD Million)

Table 44. Asia-Pacific Tardive Dyskinesia Revenue by Application (2023-2028) & (USD Million)

Table 45. Asia-Pacific Tardive Dyskinesia Revenue by Region (2017-2022) & (USD Million)

Table 46. Asia-Pacific Tardive Dyskinesia Revenue by Region (2023-2028) & (USD Million)

Table 47. South America Tardive Dyskinesia Revenue by Type (2017-2022) & (USD Million)

Table 48. South America Tardive Dyskinesia Revenue by Type (2023-2028) & (USD Million)

Table 49. South America Tardive Dyskinesia Revenue by Application (2017-2022) & (USD Million)

Table 50. South America Tardive Dyskinesia Revenue by Application (2023-2028) & (USD Million)

Table 51. South America Tardive Dyskinesia Revenue by Country (2017-2022) & (USD Million)

Table 52. South America Tardive Dyskinesia Revenue by Country (2023-2028) & (USD Million)

Table 53. Middle East & Africa Tardive Dyskinesia Revenue by Type (2017-2022) & (USD Million)

Table 54. Middle East & Africa Tardive Dyskinesia Revenue by Type (2023-2028) & (USD Million)

Table 55. Middle East & Africa Tardive Dyskinesia Revenue by Application (2017-2022) & (USD Million)

Table 56. Middle East & Africa Tardive Dyskinesia Revenue by Application (2023-2028) & (USD Million)

Table 57. Middle East & Africa Tardive Dyskinesia Revenue by Country (2017-2022) & (USD Million)

Table 58. Middle East & Africa Tardive Dyskinesia Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Tardive Dyskinesia Picture

Figure 2. Global Tardive Dyskinesia Revenue Market Share by Type in 2021

Figure 3. Dopamine-Depleting Medications

Figure 4. GABA Receptor Agonist Medications

Figure 5. Anticholinergic Medications

Figure 6. Tardive Dyskinesia Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Ambulatory Surgical Centers Picture

Figure 9. Diagnostic Centers Picture

Figure 10. Global Tardive Dyskinesia Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Tardive Dyskinesia Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Tardive Dyskinesia Revenue Market Share by Region (2017-2028)

Figure 13. Global Tardive Dyskinesia Revenue Market Share by Region in 2021

Figure 14. North America Tardive Dyskinesia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Tardive Dyskinesia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Tardive Dyskinesia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Tardive Dyskinesia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Tardive Dyskinesia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Tardive Dyskinesia Market Drivers

Figure 20. Tardive Dyskinesia Market Restraints

Figure 21. Tardive Dyskinesia Market Trends

Figure 22. Bausch Health Recent Developments and Future Plans

Figure 23. Neurocrine Biosciences Recent Developments and Future Plans

Figure 24. Teva Pharmaceuticals Industries Recent Developments and Future Plans

Figure 25. Global Tardive Dyskinesia Revenue Share by Players in 2021

Figure 26. Tardive Dyskinesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 27. Global Top 3 Players Tardive Dyskinesia Revenue Market Share in 2021

Figure 28. Global Top 10 Players Tardive Dyskinesia Revenue Market Share in 2021

Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 30. Global Tardive Dyskinesia Revenue Share by Type in 2021

Figure 31. Global Tardive Dyskinesia Market Share Forecast by Type (2023-2028)

Figure 32. Global Tardive Dyskinesia Revenue Share by Application in 2021

Figure 33. Global Tardive Dyskinesia Market Share Forecast by Application (2023-2028)

Figure 34. North America Tardive Dyskinesia Sales Market Share by Type (2017-2028)

Figure 35. North America Tardive Dyskinesia Sales Market Share by Application (2017-2028)

Figure 36. North America Tardive Dyskinesia Revenue Market Share by Country (2017-2028)

Figure 37. United States Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 38. Canada Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Mexico Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Europe Tardive Dyskinesia Sales Market Share by Type (2017-2028)

Figure 41. Europe Tardive Dyskinesia Sales Market Share by Application (2017-2028)

Figure 42. Europe Tardive Dyskinesia Revenue Market Share by Country (2017-2028)

Figure 43. Germany Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. France Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. United Kingdom Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Russia Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Italy Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Asia-Pacific Tardive Dyskinesia Sales Market Share by Type (2017-2028)

Figure 49. Asia-Pacific Tardive Dyskinesia Sales Market Share by Application (2017-2028)

Figure 50. Asia-Pacific Tardive Dyskinesia Revenue Market Share by Region (2017-2028)

Figure 51. China Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Japan Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. South Korea Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. India Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Southeast Asia Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Australia Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. South America Tardive Dyskinesia Sales Market Share by Type (2017-2028)

Figure 58. South America Tardive Dyskinesia Sales Market Share by Application (2017-2028)

Figure 59. South America Tardive Dyskinesia Revenue Market Share by Country (2017-2028)

Figure 60. Brazil Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Argentina Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Middle East and Africa Tardive Dyskinesia Sales Market Share by Type (2017-2028)

Figure 63. Middle East and Africa Tardive Dyskinesia Sales Market Share by Application (2017-2028)

Figure 64. Middle East and Africa Tardive Dyskinesia Revenue Market Share by Country (2017-2028)

Figure 65. Turkey Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Saudi Arabia Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. UAE Tardive Dyskinesia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Methodology

Figure 69. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz